Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma.
about
Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity.Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS- Mutant Cancers.Advances in studies of tyrosine kinase inhibitors and their acquired resistance.Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation.
P2860
Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sorafenib: a review of its use ...... ferentiated thyroid carcinoma.
@en
type
label
Sorafenib: a review of its use ...... ferentiated thyroid carcinoma.
@en
prefLabel
Sorafenib: a review of its use ...... ferentiated thyroid carcinoma.
@en
P2860
P1433
P1476
Sorafenib: a review of its use ...... ferentiated thyroid carcinoma.
@en
P2093
Hannah A Blair
P2860
P2888
P304
P356
10.1007/S11523-015-0363-Z
P577
2015-03-07T00:00:00Z
P6179
1047127353